Add to Cart
Creatine i (CTnI) is a special protein in myocardial cells. It has the function of regulating myocardial cell contraction. It is widely applied in the clinical diagnosis of myocardial damage and unstable angina. In these patients, ctni appears earlier and lasts longer. Myocardial specificity, which is the first diagnostic index of myocardial infarction, requires a relatively long diagnosis time.
Detection range | sample size | Sample type | Test time |
0.1~50ng/mL | 60μl | Whole blood / serum / plasma | 15min |
See a doctor | Chest pain / tightness | |||
Medical records and physical examinations | Suspected ACS (Acute Coronary syndrome) | |||
electrocardiogram | Persistent ST segment elevation | Abnormal St/T segment ↓ | ECG normal ↓ | |
Biochemical test | ↓Confirm | CTN was positive | Troponin CTN negative ×2 | |
Risk stratification | high-risk | Low risk | ||
diagnosis | St-segment elevation myocardial infarction | NSTEMI in non ST segment elevation myocardial infarction | UA of unstable angina pectoris | |
treatment | Reperfusion | interventional therapy | Non interventional therapy |
Cardiology, emergency, examination room, pediatrics, hematology, oncology, Nephrology, surgery, etc.
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, microbial series,
biochemical series and immune series reagents and supporting
instruments.
The company has always adhered to the core concept of "fast and
accurate, living up to life", committed to providing society with
excellent products and services, and contributing to the cause of
human health.